fda approval of tirzepatide for weight loss Introducing NOW AVAILABLE at Trim and Tone! The approved tirzepatide along with semaglutide in people without diabetes. It's the first medication in its class and comes as FDA approves Eli Lilly's Zepbound,

For informational purposes only not medical advice

This option suits patients experiencing positive results with Mounjaro who prefer maintaining their current treatment protocol rather than transitioning to alternative medications

Long-Term Planning: Our team discusses long-term considerations, including monitoring, financial aspects, and exploring insurance coverage

Um, a lot of these things are accidental, uh, where people like, my autoimmune disease is getting better, my allergies are getting better

In three years' time, Blue Cross saw the annual cost of claims from the weight loss drugs soar from $8 million to $100 million